Format

Send to

Choose Destination
See comment in PubMed Commons below
J Cancer Res Ther. 2010 Jul-Sep;6(3):344-6. doi: 10.4103/0973-1482.73356.

Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.

Author information

1
Department of Medical Oncology, M. S. Ramaiah Medical College, Bangalore 560 054, India. drmuralisubramanian@gmail.com

Abstract

Rituximab is a chimeric anti-CD20 monoclonal antibody used to treat CD20+ non-Hodgkin's lymphoma (NHL). Some pulmonary adverse reactions such as cough, rhinitis, bronchospasm and dyspnea are relatively common. Severe respiratory conditions like cryptogenic organizing pneumonia, interstitial pneumonitis have rarely been reported. We present a case of interstitial pneumonitis in a patient who was treated with R-CHOP for extranodal NHL. He responded to the steroids.

PMID:
21119272
DOI:
10.4103/0973-1482.73356
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Medknow Publications and Media Pvt Ltd
    Loading ...
    Support Center